Navigation Links
Hologic Announces Two-For-One Stock Split
Date:1/30/2008

equity incentive plans. If such approval is not obtained, no dividend will be issued.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com.

Forward Looking Disclaimer

This News Release contains forward-looking information that involves risks and uncertainties, including statements about the approval of the amendment to Hologic's Certificate of Incorporation at the annual meeting of stockholders and the payment of the stock dividend. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Actual results could differ materially from Hologic's current expectations as a result of numerous factors, including the risk that the stockholders do not approve the amendment to Hologic's Certificate of Incorporation, in which case the stock dividend would not be paid. Other factors that could adversely affect Hologic's business and prospects are described in Hologic's filings with the Securities and Exchange Commission. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Hologic's expectations or any change in events, conditions or circumstances on which any such statement is based.

Add
'/>"/>

SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Does Pathological Shyness Make for School Shooters?
2. U of M study: Health food supplement may curb addiction of pathological gamblers
3. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
4. Hologic to Present at the UBS Global Life Sciences Conference
5. Hologic Acquires Biolucent, Inc.
6. Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2, 2007
7. ISS Recommends Hologic Stockholders Vote FOR Merger With Cytyc
8. 1 in 5 bariatric surgery candidates not psychologically cleared for surgery
9. Hologic Stockholders Approve Merger with Cytyc
10. Exercise and psychological counseling could ease cancer-related fatigue
11. Cancer care providers need to proactively address patients psychological and social needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... A cleanroom manufacturing company has ...eanrooms. The feature is a utility panel which ca...nce the cleanroom appearance. , ...Gerbig Engineering, a designer, fabricator and ins...they are now offering a utility panel for integrat...
(Date:7/23/2008)...und,s Commitment to Meet the Financing Needs of Eu...and Institutions--, NEW YORK, July 24 /PRNewswire...n Macleod, Ph.D., has been promoted to Partner. Ba...s responsible for sourcing,evaluating and negotia...rtunities for the Paul Capital Healthcare funds., ...
(Date:7/23/2008)...M, N.C. A study out of Wake Forest University Bap...ctors are correctly identifying patients who are h...aven,t yet confirmed it. , The study used data f...ts with heart attack symptoms who were admitted to...g U.S. centers. , The findings were released to...
(Date:7/23/2008)...d Problem For 10+ Years Even Though Some Kilns Emi...n Cement Kilns in AL, CA, IA,IL, MD, MI, MT, NY, ...wire-USNewswire/ -- For more than a decade,after C...n from cement,kilns across the nation, the U.S. En...e action. Now, a new study from Earthjustice and t...
Breaking Medicine News(10 mins):Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7
... Health Organization estimates that 40 million peo.../of them in developing countries. In some African ...irus. Last year, an estimated 700,000 children cau...the risk is greatest, researchers have settled on ...
Cholesterol-lowering drug Found To greatly Reduce the risk of stroke and heart attack
...ncer survivors can now get up and get moving. Brea... older women, reported higher body esteem and bett...a new study. Researchers compared 40 women who sa...ary women, all early-stage breast cancer survivors...
... took the most antibiotics , or who took the drugs... // developing breast cancer over an average of ab...he drugs, the study showed. Also, since antibiotic...common infections caused by bacteria, some pneumon...
Other Medicine News:Health News:Drug to stop HIV spread to babies may Indirectly harm The Mother 2
(Date:7/22/2008)...dy Demonstrates Feasibility and Efficacy of Treati...Liver Cancer, SAN FRANCISCO, and YONGIN-SI, South...n Francisco, CA and Ottawa, Ontario), and its Sout...y that novel findings from,a Phase I clinical tria...trated that the product was well-tolerated and res...
(Date:7/22/2008)...UTH SAN FRANCISCO, Calif., July 22 /-...it has completed patient enrollment,in its Phase 1...lity and,ammonia scavenging effects of HPN-100 (fo...nylbutyrate) in patients with urea cycle disorders...ults in the fourth quarter,of this year., (Logo: ...
(Date:7/22/2008)...PHIA ANTIPOLIS, France, July 22 /PRNewswire-FirstC...ounced it has successfully completed the,enrollmen...led hypertension,in two clinical pharmacology stud...announced timelines. These trials are designed to ...in comparison to ibuprofen and,naproxen, using the...
(Date:7/21/2008)...W YORK, July 21 /- Ari Kiev, M.D., pr...d speaker at the upcoming conference Wall,Street U...gement,s Guide to,Wall Street. The conference will...Terrace, 267 Fifth Avenue in New York. The event i...nd mid-cap life science companies to gain,better i...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 12478 1Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 12478 2Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 12478 3Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 12478 4Genta Announces Senior Management Changes 3457 1Genta Announces Senior Management Changes 3457 2Genta Announces Senior Management Changes 3457 3Genta Announces Senior Management Changes 3457 4ThermoGenesis Corp Announces Voluntary Recall of Selected Lots of AXP Bag Sets 3455 1ThermoGenesis Corp Announces Voluntary Recall of Selected Lots of AXP Bag Sets 3455 2Bacteria and nanofilters the future of clean water technology 2295 1Bacteria and nanofilters the future of clean water technology 2295 2
...Survival Benefit in,Liver Cancer -, CHICAGO, June ...e Pharmaceuticals Inc. and Onyx Pharmaceuticals, I...blets significantly,extended overall survival in p...imary liver cancer versus those taking placebo by ...ted at the 43rd,annual meeting of the American Soc...
... - Researchers at,Molecular Insight Pharmaceutical...data on MIP-1072, a radiolabeled, small molecule,m... diagnosis and,staging of prostate cancer at the 5...ine (SNM) in Washington, D.C. MIP-1072 is,one of t...nosis,that Molecular Insight plans to advance into...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 4
...rocleix System has added a significant layer of a ...nnovative technologies developed by Gen-Probe incl...plification technique called Transcription-Mediate...ay can simultaneously detect the presence of HIV-1...
...Antibody Test (Reveal Test) is MedMiras flagship r...an serum or plasma against HIV-1 that are produced...eal Test is based on MedMiras proprietary flow-thr...ngle-use test cartridge containing an immunoreacti...
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple
X-Hair Trephines
Medicine Products: